HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,796 | +12.3% | 5,124 | -0.2% | 0.01% | +12.5% |
| Q2 2023 | $527,826 | -5.9% | 5,132 | -0.2% | 0.01% | -11.1% |
| Q1 2023 | $561,198 | -8.8% | 5,142 | -4.9% | 0.01% | -10.0% |
| Q4 2022 | $615,203 | +69.5% | 5,406 | -7.7% | 0.01% | +42.9% |
| Q3 2022 | $363,000 | -76.1% | 5,860 | -69.3% | 0.01% | -75.9% |
| Q2 2022 | $1,522,000 | -30.8% | 19,088 | -8.7% | 0.03% | -21.6% |
| Q1 2022 | $2,200,000 | -7.1% | 20,914 | -4.8% | 0.04% | -2.6% |
| Q4 2021 | $2,368,000 | -1.6% | 21,978 | +0.0% | 0.04% | -17.4% |
| Q3 2021 | $2,407,000 | +17.0% | 21,971 | 0.0% | 0.05% | +12.2% |
| Q2 2021 | $2,057,000 | +1.7% | 21,971 | 0.0% | 0.04% | -8.9% |
| Q1 2021 | $2,022,000 | +25.8% | 21,971 | 0.0% | 0.04% | +12.5% |
| Q4 2020 | $1,607,000 | -8.6% | 21,971 | -2.9% | 0.04% | -21.6% |
| Q3 2020 | $1,758,000 | +60.3% | 22,625 | +14.6% | 0.05% | +50.0% |
| Q2 2020 | $1,097,000 | – | 19,740 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |